p90RSK2, a new MLCK, rescues contractility in myosin light chain kinase null smooth muscle

p90RSK2,一种新的MLCK,可恢复肌球蛋白轻链激酶缺失平滑肌的收缩力。

阅读:1

Abstract

BACKGROUND: Phosphorylation of smooth muscle (SM) myosin regulatory light chain (RLC (20) ) is a critical switch leading to contraction or cell migration. The canonical view held that the only kinase catalyzing this reaction is the short isoform of myosin light chain kinase (MLCK1). Auxiliary kinases may be involved and play a vital role in blood pressure homeostasis. We have previously reported that p90 ribosomal S6 kinase (RSK2) functions as such a kinase, in parallel with the classical MLCK1, contributing ∼25% of the maximal myogenic force in resistance arteries and regulating blood pressure. Here, we take advantage of a MLCK1 null mouse to further test our hypothesis that RSK2 can function as an MLCK, playing a significant physiological role in SM contractility. METHODS: Fetal (E14.5-18.5) SM tissues were used as embryos die at birth. We investigated the necessity of MLCK for contractility, cell migration and fetal development and determined the ability of RSK2 kinase to compensate for the lack of MLCK and characterized it's signaling pathway in SM. RESULTS: Agonists induced contraction and RLC (20) phosphorylation in mylk1 (-/-) SM, that was inhibited by RSK2 inhibitors. Embryos developed and cells migrated in the absence of MLCK. The pCa-tension relationships in WT vs mylk1 (-/-) muscles demonstrated a Ca (2+) -dependency due to the Ca (2+) -dependent tyrosine kinase Pyk2, known to activate PDK1 that phosphorylates and fully activates RSK2. The magnitude of contractile responses was similar upon addition of GTPγS to activate the RhoA/ROCK pathway. The Ca (2+) -independent component was through activation of Erk1/2/PDK1/RSK2 leading to direct phosphorylation of RLC (20) , to increase contraction. RSK2, PDK1, Erk1/2 and MLCK formed a signaling complex on the actin filament, optimally positioning them for interaction with adjacent myosin heads. CONCLUSIONS: RSK2 signaling constitutes a new third signaling pathway, in addition to the established Ca (2+) /CAM/MLCK and RhoA/ROCK pathways to regulate SM contractility and cell migration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。